The human kallikrein 5 protein (hK5) is expressed in many normal tissues, most
notably in skin, breast, salivary gland and esophagus. It has also been shown to
be a potential biomarker for breast, ovarian and testicular cancer. Human
kallikrein 3 (hK3; prostate-specific antigen) is the most useful marker for
adenocarcinoma of the prostate gland. The aim of this study was to determine
whether hK3 and hK5 are expressed in salivary gland tissues and salivary gland
tumors (both benign and malignant), in order to compare normal with tumor
tissues. Pleomorphic adenomas, adenoid cystic carcinomas, polymorphous low-grade
adenocarcinomas, acinic cell carcinomas, mucoepidermoid carcinomas and
adenocarcinomas not otherwise specified of both minor and major salivary glands
were examined. The results of this study indicate that most salivary gland
tumors do not show high levels of expression of hK5. Staining was most prominent
in keratinizing epithelia in pleomorphic adenomas. hK3 is not expressed in
salivary gland tumors.
BarryM.J.Clinical practice. Prostate-specific-antigen testing for early
diagnosis of prostate cancer.N Engl J Med2001; 344:
1373–7.
11.
LundwallA.Characterization of the gene for prostate-specific antigen, a
human glandular kallikrein.Biochem Biophys Res Commun1989; 161:
1151–9.
12.
OlssonA.Y.,
BjartellA.,
LiljaH.,
LundwallA.Expression of prostate-specific antigen (PSA) and human glandular
kallikrein 2 (hK2) in ileum and other extraprostatic
tissues.Int J Cancer2005; 113:
290–7.
13.
YousefG.M.,
DiamandisE.P.The new kallikrein-like gene, KLK-L2. Molecular characterization,
mapping, tissue expression, and hormonal regulation.J Biol Chem1999; 274:
37511–6.
14.
MichaelI.P.,
PampalakisG.,
MikolajczykS.D.,
MalmJ.,
SotiropoulouG.,
DiamandisE.P.Human tissue kallikrein 5 is a member of a proteolytic cascade
pathway involved in seminal clot liquefaction and potentially in prostate
cancer progression.J Biol Chem2006; 281:
12743–50.
15.
MichaelI.P.,
SotiropoulouG.,
PampalakisG.Biochemical and enzymatic characterization of human kallikrein 5
(hK5), a novel serine protease potentially involved in cancer
progression.J Biol Chem2005; 280:
14628–35.
16.
KurlenderL.,
YousefG.M.,
MemariN.Differential expression of a human kallikrein 5 (KLK5) splice
variant in ovarian and prostate cancer.Tumour Biol2004; 25:
149–56.
17.
DiamandisE.P.,
BorgonoC.A.,
ScorilasA.Immunofluorometric quantification of human kallikrein 5
expression in ovarian cancer cytosols and its association with unfavorable
patient prognosis.Tumour Biol2003; 24:
299–309.
18.
EllisG.L.,
AuclairP.L.Atlas of Tumor Pathology: Tumors of the Salivary Glands.Washington, D.C.: Armed Forces
Institute of Pathology1996; 39–56;
155–228.
19.
BlackM.H.,
MagklaraA.,
ObiezuC.V.,
MelegosD.N.,
DiamandisE.P.Development of an ultrasensitive immunoassay for human glandular
kallikrein with no cross-reactivity from prostate-specific
antigen.Clin Chem1999; 45:
790–9.
20.
YousefG.M.,
PolymerisM.E.,
GrassL.Human kallikrein 5: a potential novel serum biomarker for breast
and ovarian cancer.Cancer Res2003; 63:
3958–65.
21.
AllredD.C.,
ClarkG.M.,
ElledgeR.Association of p53 protein expression with tumor cell
proliferation rate and clinical outcome in node-negative breast
cancer.J Nat Cancer Inst1993; 85:
200–6.
22.
TuckA.B.,
O'MalleyF.P.,
SinghalH.Osteopontin expression in a group of lymph node negative breast
cancer patients.Int J Cancer1998; 79:
502–8.
23.
StameyT.A.,
YangN.,
HayA.R.,
McNealJ.E.,
FreihaF.S.,
RedwineE.Prostate-specific antigen as a serum marker for adenocarcinoma of
the prostate.N Engl J Med1987; 317:
909–16.
MagklaraA.,
ScorilasA.,
KatsarosD.The human KLK8 (neuropsin/ovasin) gene: identification of two
novel splice variants and its prognostic value in ovarian
cancer.Clin Cancer Res2001; 7:
806–11.
27.
KishiT.,
GrassL.,
SoosaipillaiA.Human kallikrein 8, a novel biomarker for ovarian
carcinoma.Cancer Res2003; 63:
2771–4.
28.
YousefG.M.,
ObiezuC.V.,
JungK.,
StephanC.,
ScorilasA.,
DiamandisE.P.Differential expression of kallikrein gene 5 in cancerous and
normal testicular tissues.Urology2002; 60:
714–8.
29.
YousefG.M.,
ScorilasA.,
ChangA.Down-regulation of the human kallikrein gene 5 (KLK5) in prostate
cancer tissues.Prostate2002; 51:
126–32.
30.
KimH.,
ScorilasA.,
KatsarosD.Human kallikrein gene 5 (KLK5) expression is an indicator of poor
prognosis in ovarian cancer.Br J Cancer2001; 84:
643–50.
31.
YousefG.M.,
ScorilasA.,
KyriakopoulouL.G.Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an
independent indicator of poor prognosis in breast cancer.Clin Chem2002; 48:
1241–50.
32.
BrattsandM.,
EgelrudT.Purification, molecular cloning, and expression of a human
stratum corneum trypsin-like serine protease with possible function in
desquamation.J Biol Chem1999; 274:
30033–40.
33.
BrattsandM.,
StefanssonK.,
LundhC.,
HaasumY.,
EgelrudT.A proteolytic cascade of kallikreins in the stratum
corneum.J Invest Dermatol2005; 124:
198–203.
